Rafael Holdings, Inc. (NYSE:RFL) Short Interest Up 30.1% in December

Rafael Holdings, Inc. (NYSE:RFL) was the recipient of a significant growth in short interest in December. As of December 31st, there was short interest totaling 52,381 shares, a growth of 30.1% from the December 15th total of 40,257 shares. Based on an average daily trading volume, of 171,579 shares, the short-interest ratio is presently 0.3 days. Currently, 0.2% of the company’s stock are sold short. Currently, 0.2% of the company’s stock are sold short. Based on an average daily trading volume, of 171,579 shares, the short-interest ratio is presently 0.3 days.

Rafael Stock Performance

NYSE RFL traded up $0.01 on Monday, hitting $1.25. 41,107 shares of the stock traded hands, compared to its average volume of 96,071. The business’s fifty day moving average is $1.26 and its two-hundred day moving average is $1.46. Rafael has a 12 month low of $1.12 and a 12 month high of $3.19. The firm has a market capitalization of $64.71 million, a price-to-earnings ratio of -1.47 and a beta of 0.67.

Rafael (NYSE:RFL) last issued its quarterly earnings results on Wednesday, October 29th. The company reported ($0.28) EPS for the quarter. Rafael had a negative net margin of 3,044.70% and a negative return on equity of 32.82%. The firm had revenue of $0.89 million for the quarter.

Institutional Trading of Rafael

A number of institutional investors have recently modified their holdings of RFL. Geode Capital Management LLC grew its position in Rafael by 72.9% during the second quarter. Geode Capital Management LLC now owns 451,139 shares of the company’s stock worth $781,000 after buying an additional 190,179 shares in the last quarter. Vanguard Group Inc. raised its holdings in shares of Rafael by 10.5% in the 3rd quarter. Vanguard Group Inc. now owns 1,394,726 shares of the company’s stock valued at $1,897,000 after acquiring an additional 133,024 shares in the last quarter. Cable Car Capital LP bought a new stake in shares of Rafael during the 2nd quarter valued at about $173,000. Americana Partners LLC bought a new stake in shares of Rafael during the 2nd quarter valued at about $76,000. Finally, Citadel Advisors LLC grew its holdings in shares of Rafael by 132.3% during the third quarter. Citadel Advisors LLC now owns 72,584 shares of the company’s stock worth $99,000 after purchasing an additional 41,335 shares in the last quarter. 11.30% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Rafael in a report on Monday, December 22nd. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Sell”.

About Rafael

Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia.